Sight Sciences SGHT
NASDAQ SGHT
$8.22 -0.25 (-2.95%)
At close: Aug 20, 2026 · 1:10 PM UTC

Sight Sciences (SGHT) Operating Leases (2023 - 2026)

Sight Sciences (SGHT) posted quarterly Operating Leases of $870000.0 for Q1 2026, up 165.24% year-over-year from $328000.0 in Q1 2025, and up 1751.06% quarter-over-quarter from $47000.0 in Q3 2025.

Sight Sciences (SGHT) Operating Leases (2023 - 2026) Analysis & Trends

Sight Sciences' Operating Leases history runs 4 years deep, the most recent figure standing at $870000.0 for Q1 2026.

  • In Q1 2026, Operating Leases rose 165.24% year-over-year to $870000.0; the TTM figure through Mar 2026 stood at $870000.0 (up 165.24% YoY), while the FY2024 annual figure was $473000.0, down 48.25% from the prior year.
  • Operating Leases for Q1 2026 stood at $870000.0, up from $47000.0 in the prior quarter.
  • The five-year high for Operating Leases was $914000.0 in Q4 2023, with the low at $47000.0 in Q3 2025.
  • The 4-year median for Operating Leases is $543500.0 (2024), against an average of $522000.0.
  • The sharpest annual moves came in 2025 and 2026: Operating Leases sank 92.35% in 2025, then soared 165.24% in 2026.
  • Sight Sciences' Operating Leases stood at $914000.0 in 2023, then tumbled by 48.25% to $473000.0 in 2024, then slumped by 90.06% to $47000.0 in 2025, then surged by 1751.06% to $870000.0 in 2026.
  • Business Quant data shows SGHT's Operating Leases at $870000.0 in Q1 2026, $47000.0 in Q3 2025, and $183000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn
10 Sight Sciences 448.04 Mn 368.28 Mn 21.37 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 804,000.00
Mar 31, 2026 870,000.00
Sep 30, 2025 47,000.00
Jun 30, 2025 183,000.00
Mar 31, 2025 328,000.00
Dec 31, 2024 473,000.00
Sep 30, 2024 614,000.00
Jun 30, 2024 747,000.00
Dec 31, 2023 914,000.00